Monday, March 27, 2017

World Congress Manufacturers’ 340B Summit

World Congress Manufacturers’ 340B Summit
May 16-17, 2017 | Philadelphia

Join pharmaceutical manufacturers, thought leaders, and leading regulatory strategists at the World Congress Manufacturers’ 340B Summit, May 16-17, in Philadelphia. This event will dive deep into the strategic, operational, legal and regulatory implications to pharma manufacturers of the evolving health care landscape around 340B.

Through high-level discussion:
  • Create strategies for managing pricing calculations and average ceiling prices
  • Overcome operational challenges to better align refund strategies
  • Improve self-disclosure reporting while building better relationships with covered entity
  • Gain legal insights and considerations around 340B to better prepare for the changing landscape
  • Review trends, findings and preparation strategies for increased HRSA audits
Confirmed speakers include executives from Pfizer, J&J, BMS, Fresenius Medical Care, Hogan Lovells, King & Spalding, Sidley, State of Oregon, University of Chicago, NACDS.

To learn more or register for this event, visit here. Rates start at $995 for pharmaceutical manufacturers. Drug Channels readers can use discount code DC200 to save $200!

This event, co-located with the 2nd Annual Covered Entities’ 340B Summit, provides comprehensive coverage of the 340B program.

CPE Credits and CLE Credits* are available.

*CLE Pending approval

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...